STLN earnings
Starling Oncology (STLN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
STLN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 5, 2026 | -0.13 | – | – | $169.77M |
| Q2 2026 | Aug 6, 2026 | -0.08 | -0.06 | -25.00% | $161.28M |
| Q1 2026 | May 7, 2026 | -0.02 | -0.09 | 77.14% | $147.44M |
| Q4 2025 | Mar 12, 2026 | -0.06 | – | – | $141.96M |
| Q3 2025 | Nov 13, 2025 | -0.14 | – | – | $136.56M |
| Q2 2025 | Aug 13, 2025 | -0.15 | -0.12 | -25.00% | $119.80M |
| Q1 2025 | May 14, 2025 | -0.21 | – | – | $104.41M |
| Q4 2024 | Mar 24, 2025 | -0.14 | – | – | $100.27M |
| Q3 2024 | Nov 13, 2024 | -0.18 | – | – | $99.90M |
| Q2 2024 | Aug 13, 2024 | -0.17 | -0.09 | -88.89% | $98.58M |
| Q1 2024 | May 14, 2024 | -0.22 | – | – | $94.67M |
| Q4 2023 | Mar 27, 2024 | -0.21 | – | – | $85.79M |
| Q3 2023 | Nov 8, 2023 | -0.19 | – | – | $82.03M |
| Q2 2023 | Aug 8, 2023 | -0.19 | – | – | $80.22M |
| Q1 2023 | May 10, 2023 | -0.33 | – | – | $76.19M |
| Q4 2022 | Mar 9, 2023 | -0.12 | – | – | $71.42M |
| Q3 2022 | Nov 9, 2022 | -0.17 | – | – | $64.98M |
- STLN beat EPS estimates in 1 of its last 4 reports.
Updated 2026-11-11 00:49 UTC